Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
4.030
+0.070 (1.77%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 427 employees as of December 31, 2024. The number of employees decreased by 25 or -5.53% compared to the previous year.
Employees
427
Change (1Y)
-25
Growth (1Y)
-5.53%
Revenue / Employee
$129,396
Profits / Employee
-$782,965
Market Cap
274.88M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
PHAT News
- 21 hours ago - Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025 - GlobeNewsWire
- 6 days ago - Frazier Life Sciences Appoints Aditya Kohli to Partner - Business Wire
- 7 days ago - Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors - GlobeNewsWire
- 20 days ago - Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 22 days ago - Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - Phathom Pharmaceuticals Announces Leadership Succession - GlobeNewsWire
- 23 days ago - Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan) - GlobeNewsWire
- 6 weeks ago - Phathom Pharmaceuticals, Inc. (PHAT) Q4 2024 Earnings Call Transcript - Seeking Alpha